PA Department of Community and Economic Development
The mission of the Department of Community and Economic Development (DCED) is to foster opportunities for businesses to grow and for communities to succeed and thrive in a global economy. Our mission is to improve the quality of life for Pennsylvania citizens while assuring transparency and accountability in the expenditure of public funds.
400 North Street Harrisburg Pennsylvania 17120 United States
Overview of the sector in each of these markets with a focus on sales and partnership opportunities for Pennsylvania companies.
Israel: Pennsylvania companies have a wide choice of opportunities in the Middle East Biotech eco-sphere. These include participating in Mixii-BioMed, a world class conference and exhibition held annually in Tel Aviv; a meeting place for biotech cooperation, investment and innovation. There is also the Israel-U.S. Binational Industrial Research and Development (BIRD), which stimulates, promotes and supports industrial R&D of mutual benefit to the U.S. and Israel. BIRD provides funding for projects, including Life Sciences, and other technology sectors. Israeli and other Middle Eastern universities have various cooperation and co-development opportunities for US companies, institutes, and universities in a variety of fields.
South Korea: The COVID-19 pandemic accelerated the paradigm shift from the traditional medical industry which focused on diagnosis, treatment and hospitals to the Smart Healthcare industry that focused on disease-prevention and patient-focused care using, ICT-based technologies. Therefore, it is necessary to identify the trends and business opportunities for Pennsylvania businesses in the bio-health/bio-pharmaceutical industry in the short-term or mid- to long-term and take action accordingly.
United Kingdom: The battle against COVID-19 has never shone the spotlight on the bio and pharmaceutical industries as it has over the last nine months. With this attention comes investment. The Irish and British governments are planning to invest a combined $25 billion over the next decade to develop skills, facilities and research capability in a bid to position each of their regions as world leaders in the sector.
Innovation in this sector derives from the collaborative activities of smaller, specialist businesses, the world of academia and often the financial muscle of the global pharmaceutical giants working together. In this presentation, we will explore the ecosystem which features nine of the world’s top ten pharma companies, more than $200billion of annual global exports, and more than one hundred FDA approved facilities.
Presented by Pennsylvania’s Authorized Trade Representatives
Mr Seth Vogelman Jerusalem, Israel
Mr Ken Yang Seoul, South Korea
Mr Declan Barry Belfast, Northern Ireland, United Kingdom